Plasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathway
- PMID: 27350024
- PMCID: PMC4923873
- DOI: 10.1038/srep28042
Plasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathway
Abstract
Coronary artery disease (CAD) is one of the largest causes of death worldwide yet the traditional risk factors, although useful in identifying people at high risk, lack the desired predictive accuracy. Techniques like quantitative plasma proteomics holds immense potential to identify newer markers and this study (conducted in three phases) was aimed to identify differentially expressed proteins in stable CAD patients. In the first (discovery) phase, plasma from CAD cases (angiographically proven) and controls were subjected to iTRAQ based proteomic analysis. Proteins found to be differentially expressed were then validated in the second and third (verification and validation) phases in larger number of (n = 546) samples. After multivariate logistic regression adjusting for confounding factors (age, diet, etc.), four proteins involved in the reverse cholesterol pathway (Apo A1, ApoA4, Apo C1 and albumin) along with diabetes and hypertension were found to be significantly associated with CAD and could account for approximately 88% of the cases as revealed by ROC analysis. The maximum odds ratio was found to be 6.70 for albumin (p < 0.0001), followed by Apo AI (5.07, p < 0.0001), Apo CI (4.03, p = 0.001), and Apo AIV (2.63, p = 0.003). Down-regulation of apolipoproteins and albumin implicates the impairment of reverse cholesterol pathway in CAD.
Figures
Similar articles
-
Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.Int J Cardiol. 2005 Jun 8;101(3):435-40. doi: 10.1016/j.ijcard.2004.03.057. Int J Cardiol. 2005. PMID: 15907412
-
Apolipoproteins: correlation with carotid intimamedia thickness and coronary artery disease.J Assoc Physicians India. 2004 May;52:370-5. J Assoc Physicians India. 2004. PMID: 15656025
-
Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.Clin Biochem. 2006 Oct;39(10):971-7. doi: 10.1016/j.clinbiochem.2006.07.003. Epub 2006 Aug 10. Clin Biochem. 2006. PMID: 16963013
-
High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations.Circulation. 1993 Apr;87(4 Suppl):III28-34. Circulation. 1993. PMID: 8462178 Review.
-
Minimally Invasive Versus Invasive Proteomics: Urine and Blood Biomarkers in Coronary Artery Disease.Proteomics Clin Appl. 2025 Jan;19(1):e202400062. doi: 10.1002/prca.202400062. Epub 2024 Nov 28. Proteomics Clin Appl. 2025. PMID: 39605279 Review.
Cited by
-
Identification of Haptoglobin as a Potential Biomarker in Young Adults with Acute Myocardial Infarction by Proteomic Analysis.Malays J Med Sci. 2020 Mar;27(2):64-76. doi: 10.21315/mjms2020.27.2.8. Epub 2020 Apr 30. Malays J Med Sci. 2020. PMID: 32788843 Free PMC article.
-
Poor Clearance of Free Hemoglobin Due to Lower Active Haptoglobin Availability is Associated with Osteoarthritis Inflammation.J Inflamm Res. 2021 Mar 18;14:949-964. doi: 10.2147/JIR.S300801. eCollection 2021. J Inflamm Res. 2021. PMID: 33776468 Free PMC article.
-
Plasma Proteome Profiling of Coronary Artery Disease Patients: Downregulation of Transthyretin-An Important Event.Mediators Inflamm. 2020 Nov 10;2020:3429541. doi: 10.1155/2020/3429541. eCollection 2020. Mediators Inflamm. 2020. PMID: 33299376 Free PMC article.
-
Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease.J Transl Med. 2018 Apr 17;16(1):104. doi: 10.1186/s12967-018-1476-9. J Transl Med. 2018. PMID: 29665821 Free PMC article.
-
Serum proteomic profiling reveals potential predictive indicators for coronary artery calcification in stable ischemic heart disease.J Mol Histol. 2025 Mar 19;56(2):110. doi: 10.1007/s10735-025-10388-5. J Mol Histol. 2025. PMID: 40106019 Free PMC article.
References
-
- Lim S. S. et al.. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2224–2260, doi: 10.1016/S0140-6736(12)61766-8 (2012). - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous